Thromboembolism Risk Profiles in Non-valvular Atrial Fibrillation: How Can Machine Learning-Based Analysis Add to Our Understanding?
作者信息
Goldin Mark, Spyropoulos Alex C
机构信息
Northwell, 2000 Marcus Ave., Suite 300, New Hyde Park, NY, 11042-1069, USA.
Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA.
出版信息
J Gen Intern Med. 2025 May;40(6):1224-1226. doi: 10.1007/s11606-025-09372-2.
Abstract
摘要
相似文献
1
Thromboembolism Risk Profiles in Non-valvular Atrial Fibrillation: How Can Machine Learning-Based Analysis Add to Our Understanding?非瓣膜性心房颤动的血栓栓塞风险概况：基于机器学习的分析如何增进我们的理解？
J Gen Intern Med. 2025 May;40(6):1224-1226. doi: 10.1007/s11606-025-09372-2.
2
Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.非瓣膜性心房颤动患者左心耳封堵与非维生素 K 口服抗凝剂的头对头比较：系统评价和荟萃分析研究。
Trends Cardiovasc Med. 2024 May;34(4):225-233. doi: 10.1016/j.tcm.2023.02.002. Epub 2023 Feb 10.
3
Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.测试新型口服抗凝剂在骨科手术中预防血栓形成以及在心房颤动中预防中风方面的治疗等效性。
Int J Clin Pharmacol Ther. 2015 Mar;53(3):211-9. doi: 10.5414/CP202183.
4
A Systematic Review on the Effectiveness of Machine Learning in the Detection of Atrial Fibrillation.关于机器学习在心房颤动检测中有效性的系统评价
Curr Cardiol Rev. 2025;21(1):e310724232529. doi: 10.2174/011573403X293703240715104503.
5
Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis.肥厚型心肌病伴或不伴心房颤动患者的缺血性事件：系统评价和荟萃分析。
J Thromb Thrombolysis. 2023 Jan;55(1):83-91. doi: 10.1007/s11239-022-02713-6. Epub 2022 Oct 3.
6
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历：系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
7
Fair prediction of 2-year stroke risk in patients with atrial fibrillation.心房颤动患者2年中风风险的准确预测。
J Am Med Inform Assoc. 2024 Dec 1;31(12):2820-2828. doi: 10.1093/jamia/ocae170.
8
9
Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis.真实世界证据比较非瓣膜性心房颤动的口服抗凝药物：系统评价和网络荟萃分析。
Future Cardiol. 2022 May;18(5):393-405. doi: 10.2217/fca-2021-0120. Epub 2022 Apr 1.
10
Prediction model of atrial fibrillation recurrence after Cox-Maze IV procedure in patients with chronic valvular disease and atrial fibrillation based on machine learning algorithm.基于机器学习算法的慢性瓣膜病合并心房颤动患者 Cox-Maze IV 术后心房颤动复发预测模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Jul 28;48(7):995-1007. doi: 10.11817/j.issn.1672-7347.2023.230018.
本文引用的文献
1
Atrial fibrillation: epidemiology, screening and digital health.心房颤动：流行病学、筛查与数字健康。
Lancet Reg Health Eur. 2024 Feb 1;37:100786. doi: 10.1016/j.lanepe.2023.100786. eCollection 2024 Feb.
2
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.代谢健康与不健康的肥胖和超重合并房颤患者的临床结局：GLORIA-AF 注册研究结果。
Mayo Clin Proc. 2024 Jun;99(6):927-939. doi: 10.1016/j.mayocp.2023.07.013. Epub 2023 Aug 25.
3
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.房颤患者遵循“房颤优化管理路径”：对 28.5 万名患者临床结局的影响——系统评价和荟萃分析。
Thromb Haemost. 2022 Mar;122(3):406-414. doi: 10.1055/a-1515-9630. Epub 2021 Jun 21.
4
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.《全球心房颤动患者长期口服抗栓治疗注册研究：一项关于心房颤动患者长期口服抗栓治疗的全球注册研究计划》
Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006. Epub 2013 Dec 19.
5
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.采用新型基于风险因素的方法对房颤患者的卒中与血栓栓塞风险进行临床分层的研究：房颤的欧洲心脏调查。
Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
6
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.体重与冠状动脉疾病的全因死亡率及心血管事件的关联：队列研究的系统评价
Lancet. 2006 Aug 19;368(9536):666-78. doi: 10.1016/S0140-6736(06)69251-9.
7
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.培哚普利降压可降低心房颤动合并既往卒中或短暂性脑缺血发作患者的主要血管事件风险。
Stroke. 2005 Oct;36(10):2164-9. doi: 10.1161/01.STR.0000181115.59173.42. Epub 2005 Sep 1.
8
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.非手术患者抗止血药品临床研究中严重出血的定义。
J Thromb Haemost. 2005 Apr;3(4):692-4. doi: 10.1111/j.1538-7836.2005.01204.x.
9
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group.医学文献用户指南：XXII：如何使用关于临床决策规则的文章。循证医学工作组
JAMA. 2000 Jul 5;284(1):79-84. doi: 10.1001/jama.284.1.79.
Zotero 插件